Annual Drug Patent Expirations for XYREM
Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for XYREM.
The generic ingredient in XYREM is sodium oxybate. Two suppliers are listed for this compound. Additional details are available on the sodium oxybate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
